Abstract:Epidemiologic and clinical features of Kawasaki Disease (KD) strongly support an infectious etiology. KD is worldwide, most prominently in Japan, Korea, and Taiwan, reflecting increased genetic susceptibility among Asian populations. In Hawaii, KD rates are 20-fold higher in Japanese ethnics than in Caucasians, intermediate in other ethnicities. The age distribution of KD, highest in children < 2 yo, lower in those < 6 months, is compatible with infection by a ubiquitous agent resulting in increasing immunity with age and with transplacental immunity, as with some classic viruses. The primarily winter-spring KD seasonality and well-documented Japanese epidemics with wave-like spread also support an infectious trigger. We hypothesize KD pathogenesis involves an RNA virus that usually causes asymptomatic infection but KD in a subset of genetically predisposed children. CD8 T cells, oligoclonal IgA, and upregulation of cytotoxic T cell and interferon pathway genes in the coronaries in fatal KD also support a viral etiology. Cytoplasmic inclusion bodies in ciliated bronchial epithelium identified by monoclonal antibodies made from oligoclonal IgA heavy chains also supports a viral etiology. Recent availability of "second generation" antibodies from KD peripheral blood plasmablasts may identify a specific viral antigen. Thus, we propose an unidentified ("new") RNA virus infects bronchial epithelium usually causing asymptomatic infection but KD in a subset of genetically predisposed children. The agent persists in inclusion bodies, with intermittent respiratory shedding, entering the bloodstream via macrophages targeting coronaries. Antigen-specific IgA plasma cells and CD8 T cells respond but coronaries can be damaged. IVIG may include antibody against the agent. Post infection, 97-99% of KD patients are immune to the agent, protected against recurrence. The agent can spread either from those with asymptomatic primary infection in winter-spring or from a previously infected contact who intermittently sheds the agent.

Advancement in Research on Kawasaki Disease

Changes in CD_(69),CD_(25) and HLA-DR Expressions in Peripheral Blood T Cells in Kawasaki Disease

Clinical features of incomplete Kawasaki disease

The Network of Pro-Inflammatory Factors CD147, DcR3, and IL33 in the Development of Kawasaki Disease.

Regulatory T cells and Kawasaki disease

The Epidemiology and Pathogenesis of Kawasaki Disease

Research Progress of Gene Polymorphism Related with Kawasaki Disease

Research Progress on the Role of Inflammation in Kawasaki Disease

Our Evolving Understanding of Kawasaki Disease Pathogenesis: Role of the Gut Microbiota

Diagnosis, Progress, and Treatment Update of Kawasaki Disease

Study Progress of Coronary Artery Damage in Kawasaki Disease

Center of Diagnosis and Treatment of Intravenous Immunoglobulin-Refractory Kawasaki Disease

Research progress of interleukin-1 and its receptor antagonist Anakinra in Kawasaki disease

An update on understanding the pathophysiology in Kawasaki disease: Possible role of immune complexes in coronary artery lesion revisited

Molecular mechanisms of endothelial dysfunction in Kawasaki-disease-associated vasculitis

An Update on Kawasaki Disease

Kawasaki Disease: An update on Genetics and Pathophysiology

Foreign Peer Effects and Stem Major Choice

Insights Into Coronary Artery Lesions in Kawasaki Disease

Emerging evidence of microbial infection in causing systematic immune vasculitis in Kawasaki disease

Optimal management of microgrids